Get the Stockscreener App
3.30
6.11%
0.19
After Hours:
3.33
0.03
+0.91%
Terns Pharmaceuticals Inc Stock (TERN) Forecast
The Terns Pharmaceuticals Inc (TERN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.4393, representing a +64.83% increase from the current price of $3.30. The highest analyst price target is $5.9375, and the lowest is $4.941.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TERN Price Target
Average 4.4483
(+34.80% Upside)
Is Terns Pharmaceuticals Inc (TERN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.75 | Neutral |
| STOCH(9,6) | 87.86 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0218 | Buy |
| ADX(14) | 31.04 | Buy |
| William %R | -1.1765 | Sell |
| CCI(14) | 100.34 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.835
Buy
|
2.8954
Buy
|
| MA20 |
2.5305
Buy
|
2.7989
Buy
|
| MA50 |
3.0729
Buy
|
3.1739
Buy
|
| MA100 |
4.1767
Sell
|
4.0211
Sell
|
| MA200 |
5.9546
Sell
|
4.9546
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, TERN could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 7 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on TERN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.75 indicates that TERN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 87.86 indicates that TERN is oversold. This means that TERN price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that TERN is oversold. This suggests that TERN price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.04 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 100.34 indicates that TERN is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term TERN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Terns Pharmaceuticals Inc financial reports and earnings history, Terns Pharmaceuticals Inc (TERN) stock could reach $10.69 by 2030, $46.66 by 2040 and $21.78 by 2050. See the projected annual prices until 2050 of the Terns Pharmaceuticals Inc stock below:
- Terns Pharmaceuticals Inc (TERN) is expected to reach an average price of $8.2495 in 2035, with a high prediction of $8.0019 and a low estimate of $8.1543. This indicates an $149.98% rise from the last recorded price of $3.30.
- Terns Pharmaceuticals Inc (TERN) stock is projected to chart a bullish course in 2040, with an average price target of $46.28, representing an $1,302% surge from its current level. The forecast ranges from a conservative $46.58 to a sky-high $46.66.
- Our analysts predict Terns Pharmaceuticals Inc (TERN) to jump 886.38% by 2045, soaring from $33.17 to an average price of $32.55, potentially reaching $32.89. While $33.17 is the low estimate, the potential upside is significant.
- Terns Pharmaceuticals Inc (TERN) stock is expected to climb by 2050, reaching an average of $21.21, a $542.62% jump from its current level. However, a wide range of estimates exists, with high and low targets of $21.78 and $21.36, respectively, highlighting the market's uncertainty.
Terns Pharmaceuticals Inc Stock (TERN) Year by Year Forecast
Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2025
Terns Pharmaceuticals Inc Stock (TERN) is expected to reach an average price of $4.3178 in 2025, with a high prediction of $7.7626 and a low estimate of $0.8731. This indicates an +30.84% rise from the last recorded price of $3.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $6.3048 | $4.941 | $5.9375 | +91.05% |
| July, 2025 | $6.8211 | $6.8073 | $6.5248 | +106.70% |
| August, 2025 | $7.0862 | $6.8584 | $6.7024 | +114.73% |
| September, 2025 | $7.9313 | $7.1475 | $7.7513 | +140.34% |
| October, 2025 | $7.4876 | $7.6576 | $7.7626 | +126.90% |
| November, 2025 | $6.5827 | $7.0127 | $7.0402 | +99.48% |
| December, 2025 | $6.689 | $6.504 | $6.439 | +102.70% |
Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2026
The predicted value for Terns Pharmaceuticals Inc (TERN) in 2026 is set at an average of $3.6914. Estimates vary from a peak of $7.3199 to a trough of $0.0629, indicating an +11.86% surge from the present price of $3.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.1141 | $4.6591 | $6.5803 | +24.67% |
| February, 2026 | $2.2892 | $3.3392 | $4.4967 | -30.63% |
| March, 2026 | $1.4243 | $2.6807 | $2.3517 | -56.84% |
| April, 2026 | $3.0406 | $1.134 | $0.9369 | -7.86% |
| May, 2026 | $1.3857 | $1.6607 | $2.752 | -58.01% |
| June, 2026 | $2.5793 | $0.4195 | $2.6493 | -21.84% |
| July, 2026 | $1.7129 | $0.0629 | $3.118 | -48.09% |
| August, 2026 | $3.3478 | $1.4217 | $4.2291 | +1.45% |
| September, 2026 | $2.0015 | $1.6465 | $3.824 | -39.35% |
| October, 2026 | $6.5264 | $2.0302 | $7.3199 | +97.77% |
| November, 2026 | $3.5614 | $3.1914 | $6.9326 | +7.92% |
| December, 2026 | $4.635 | $3.6101 | $6.6349 | +40.46% |
Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Terns Pharmaceuticals Inc (TERN) is $3.467, with a high forecast of $6.7938 and a low forecast of $0.1403. This indicates an +5.06% increase from the last price of $3.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.06 | $0.7225 | $6.7938 | -37.58% |
| February, 2027 | $0.8249 | $0.6224 | $2.4187 | -75.00% |
| March, 2027 | $0.2815 | $0.2764 | $1.6536 | -91.47% |
| April, 2027 | $0.4265 | $0.534 | $0.096 | -87.07% |
| May, 2027 | $0.2116 | $0.1403 | $0.54 | -93.59% |
| June, 2027 | $1.0979 | $0.2129 | $0.9667 | -66.73% |
| July, 2027 | $1.527 | $0.6698 | $2.3383 | -53.73% |
| August, 2027 | $1.2319 | $1.1019 | $2.5819 | -62.67% |
| September, 2027 | $2.4656 | $0.2706 | $3.1056 | -25.29% |
| October, 2027 | $3.1205 | $2.0944 | $4.0895 | -5.44% |
| November, 2027 | $2.5654 | $1.6967 | $4.5392 | -22.26% |
| December, 2027 | $1.2991 | $0.4716 | $3.4042 | -60.63% |
Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2028
In 2028, Terns Pharmaceuticals Inc (TERN) is projected to reach an average price of $8.0643, with a high projection of $15.00 and a low estimate of $1.1327. This indicates an +144.37% rise from the last price of $3.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.1751 | $1.2078 | $4.0725 | -3.79% |
| February, 2028 | $5.2752 | $1.1327 | $2.8273 | +59.86% |
| March, 2028 | $6.0179 | $5.3853 | $4.0429 | +82.36% |
| April, 2028 | $8.638 | $6.7404 | $7.6375 | +161.76% |
| May, 2028 | $10.63 | $8.9256 | $8.5407 | +222.14% |
| June, 2028 | $14.64 | $11.95 | $13.17 | +343.66% |
| July, 2028 | $12.48 | $14.12 | $15.00 | +278.21% |
| August, 2028 | $11.68 | $10.92 | $11.21 | +254.05% |
| September, 2028 | $11.63 | $12.15 | $11.62 | +252.54% |
| October, 2028 | $12.52 | $12.09 | $12.46 | +279.51% |
| November, 2028 | $13.99 | $12.64 | $13.80 | +323.84% |
| December, 2028 | $14.73 | $15.32 | $14.79 | +346.27% |
Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2029
The 2029 price forecast for Terns Pharmaceuticals Inc Stock (TERN) is $13.21 on average, with a high prediction of $17.25 and a low estimate of $9.1734. This represents an +300.39% increase from the previous price of $3.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.34 | $15.14 | $14.77 | +364.83% |
| February, 2029 | $16.44 | $15.22 | $16.07 | +398.17% |
| March, 2029 | $16.77 | $16.81 | $16.48 | +408.17% |
| April, 2029 | $16.49 | $16.60 | $16.54 | +399.69% |
| May, 2029 | $17.43 | $16.79 | $17.25 | +428.26% |
| June, 2029 | $16.88 | $16.99 | $17.22 | +411.60% |
| July, 2029 | $15.95 | $16.37 | $16.73 | +383.42% |
| August, 2029 | $15.49 | $15.47 | $15.65 | +369.26% |
| September, 2029 | $12.81 | $14.44 | $15.35 | +288.05% |
| October, 2029 | $10.72 | $11.77 | $13.02 | +224.80% |
| November, 2029 | $9.6585 | $10.96 | $10.68 | +192.68% |
| December, 2029 | $8.9087 | $9.1734 | $9.0737 | +169.96% |
Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2030
Terns Pharmaceuticals Inc Stock (TERN) is expected to reach an average price of $5.6943 in 2030, with a high forecast of $10.69 and a low forecast of $0.6947. This signifies an +72.55% surge from the last price of $3.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.1813 | $9.4563 | $10.69 | +178.22% |
| February, 2030 | $5.0215 | $6.9015 | $8.9624 | +52.17% |
| March, 2030 | $6.9016 | $6.8591 | $5.7627 | +109.14% |
| April, 2030 | $3.8218 | $5.1942 | $5.5242 | +15.81% |
| May, 2030 | $3.8444 | $4.2594 | $3.5744 | +16.50% |
| June, 2030 | $2.0346 | $2.2096 | $3.417 | -38.35% |
| July, 2030 | $2.9673 | $0.6947 | $0.5964 | -10.08% |
| August, 2030 | $0.6574 | $1.2274 | $1.4923 | -80.08% |
| September, 2030 | $4.0576 | $1.94 | $3.5276 | +22.96% |
| October, 2030 | $5.0702 | $4.3301 | $4.5877 | +53.64% |
| November, 2030 | $6.1304 | $6.1228 | $5.6978 | +85.77% |
| December, 2030 | $5.8405 | $6.0229 | $5.9129 | +76.99% |
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):